23 June 2020>: Clinical Research
The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis
Mei Tian 1BE* , Xiuchun Yang 1CD* , Yanfang Li 1BF , Sen Guo 2ABCDEFG*DOI: 10.12659/MSM.923359
Med Sci Monit 2020; 26:e923359
Table 1 Basic characters of patients with HCC.
Characters | Number | Percentage |
---|---|---|
Sex | ||
Female | 19 | 9.90% |
Male | 173 | 90.10% |
Age | ||
148 | 77.08% | |
≥60 | 44 | 22.92% |
Tumor size (cm) | ||
≤5 | 98 | 51.04% |
>5 | 94 | 48.96% |
Tumor number | ||
Single | 171 | 89.06% |
Multiple | 21 | 10.94% |
Histopathological grade | ||
I+II | 123 | 64.06% |
III | 69 | 35.94% |
Vascular invasion | ||
Negative | 127 | 66.15% |
Positive | 65 | 33.85% |
HBsAg | ||
Negative | 50 | 26.04% |
Positive | 142 | 73.96% |
HCV | ||
Negative | 179 | 93.23% |
Positive | 13 | 6.77% |
AFP | ||
109 | 56.77% | |
≥500 ng/ml | 83 | 43.23% |
T stage | ||
I | 72 | 37.50% |
II | 67 | 34.90% |
III | 49 | 25.52% |
IV | 4 | 2.08% |
Lymph invasion | ||
Negative | 190 | 98.96% |
Positive | 2 | 1.04% |
TNM stage | ||
I | 72 | 37.5% |
II | 68 | 35.4% |
III | 50 | 26.0% |
IV | 2 | 1.0% |
Dynamin 1 | ||
Low | 113 | 58.85% |
High | 79 | 41.15% |
Dynamin 2 | ||
Low | 135 | 70.31% |
High | 57 | 29.69% |
Dynamin 3 | ||
Low | 176 | 91.67% |
High | 16 | 8.33% |
HBsAg – hepatitis B surface antigen; HCV – hepatitis C virus; AFP – alpha fetoprotein. |